Showing 1601-1610 of 2526 results for "".
- Prevent Blindness Unveils New Brand Identity, Logo and Websitehttps://modernod.com/news/prevent-blindness-unveils-new-brand-identity-logo-and-website/2477772/Prevent Blindness announced the launch of its new brand identity, logo, and website. The launch coincides with the organization’s new “Be a Visionary” campaign: a call to action to join in the sight-saving efforts of Prevent Blindness. The new identity is designed to refl
- Regeneron Links With Univ. of Colorado to Sequence 450,000 Patients for Drug Researchhttps://modernod.com/news/regeneron-links-with-univ-of-colorado-to-sequence-450000-patients-for-drug-research/2477750/Regeneron Pharmaceuticals launched a new initiative that plans to sequence the DNA of 450,000 patients and compare the results with their health records, to support the company’s drug discovery and personalized medicine efforts, according to a FierceBiotech
- Seniors With COVID-19 Show Unusual Symptoms, Doctors Sayhttps://modernod.com/news/seniors-with-covid-19-show-unusual-symptoms-doctors-say/2477655/Older adults with COVID-19 have several “atypical” symptoms, complicating efforts to ensure they get timely and appropriate treatment, according to physicians, as reported by Kaiser Health News. CO
- SightGlass Vision Unveils Topline Data From Study of Novel Eyeglasses Designed to Control Myopia in Childrenhttps://modernod.com/news/sightglass-vision-unveils-topline-data-from-study-of-novel-eyeglasses-designed-to-control-myopia-in-children/2477653/SightGlass Vision announced topline data from the company’s pivotal trial evaluating its novel eyeglasses designed to slow the progression of myopia in children. Results from a planned 12-month interim analysis of the CYPRESS clinical study (NCT03623074) demonstrated a reduction in myopia p
- In Sickest COVID-19 Patients, Underlying Conditions are Common, Large Study Findshttps://modernod.com/news/in-sickest-covid-19-patients-underlying-conditions-are-common-large-study-finds/2477637/People with obesity, diabetes and high blood pressure are at greater risk for complications from the coronavirus, according to a large study of patients hospitalized with the illness it causes, as
- Student Loans, Unemployment, and Finding a Jobhttps://modernod.com/news/student-loans-unemployment-and-finding-a-job/2477625/
- Data Visualization Tool Examines Community Factors Underlying COVID-19 Outcomeshttps://modernod.com/news/data-visualization-tool-examines-community-factors-underlying-covid-19-outcomes/2477572/A new data visualization tool examines how and why COVID-19 impacts regions differently. Using daily updated data,
- New Live Video Webcast Series Aims to Unite, Educate Ophthalmologistshttps://modernod.com/news/ophthalmology-off-the-grid-on-covid-19-part-2/2477441/In a move to provide ophthalmologists and eye care professionals a platform to share timely information during the COVID-19 outbreak, Bryn Mawr Communications (BMC) this week hosted its first live video webcast via Zoom and Facebook Live. The webcast, which was made through the company’s l
- Long-Term Visual Acuity Unaffected by Intraocular Lens Implantation After Congenital-Cataract Surgeryhttps://modernod.com/news/long-term-visual-acuity-unaffected-by-intraocular-lens-implantation-after-congenital-cataract-surgery/2477357/Intraocular lens implantation at the time of surgery for congenital cataract during infancy neither improves nor worsens long-term visual acuity, compared with correction with contact lenses, according to findings from the Infant Aphakia Treatment Study (IATS), as
- Eyevance Pharmaceuticals launches Tobradex ST in the United Stateshttps://modernod.com/news/eyevance-pharmaceuticals-launches-tobradex-st-in-the-united-states/2477333/Eyevance Pharmaceuticals has announced the US launch of Tobradex ST (tobramycin/dexamethasone ophthalmic suspension) 0.3%/0.05% following the company’s acquisition of the product in late 2019. Tobradex ST is an FDA approved, fixed-dose topical antibiotic and corticosteroid combination indicated f